BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10552332)

  • 1. Tumor angiogenesis, apoptosis, and p53 oncogene in stage I lung adenocarcinoma.
    Chiba Y; Taniguchi T; Matsuyama K; Sasaki M; Kato Y; Tanaka H; Muraoka R; Tanigawa N
    Surg Today; 1999; 29(11):1148-53. PubMed ID: 10552332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor angiogenesis as a major prognostic factor in stage I lung adenocarcinoma.
    Kawaguchi T; Yamamoto S; Kudoh S; Goto K; Wakasa K; Sakurai M
    Anticancer Res; 1997; 17(5B):3743-6. PubMed ID: 9427772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor angiogenesis and biologic markers in resected stage I NSCLC.
    Lucchi M; Fontanini G; Mussi A; Vignati S; Ribechini A; Menconi GF; Bevilacqua G; Angeletti CA
    Eur J Cardiothorac Surg; 1997 Oct; 12(4):535-41. PubMed ID: 9370395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung.
    Demarchi LM; Reis MM; Palomino SA; Farhat C; Takagaki TY; Beyruti R; Saldiva PH; Capelozzi VL
    Mod Pathol; 2000 May; 13(5):511-20. PubMed ID: 10824922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study.
    Bian C; Li Z; Xu Y; Wang J; Xu L; Shen H
    World J Surg Oncol; 2015 Mar; 13():128. PubMed ID: 25890228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma.
    Shibusa T; Shijubo N; Abe S
    Clin Cancer Res; 1998 Jun; 4(6):1483-7. PubMed ID: 9626466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.
    Apolinario RM; van der Valk P; de Jong JS; Deville W; van Ark-Otte J; Dingemans AM; van Mourik JC; Postmus PE; Pinedo HM; Giaccone G
    J Clin Oncol; 1997 Jun; 15(6):2456-66. PubMed ID: 9196162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
    Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
    Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological markers in non-small cell lung cancer. Retrospective study of 10 year follow-up after surgery.
    Carbognani P; Tincani G; Crafa P; Sansebastiano G; Pazzini L; Zoni R; Bobbio A; Rusca M
    J Cardiovasc Surg (Torino); 2002 Aug; 43(4):545-8. PubMed ID: 12124571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Useful prognostic panel markers to express the biological tumor status in resected lung adenocarcinomas.
    Carvalho PE; Antonãngelo L; Bernardi FD; Leão LE; Rodrigues OR; Capelozzi VL
    Jpn J Clin Oncol; 2000 Nov; 30(11):478-86. PubMed ID: 11155917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
    Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
    Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Id-1, Id-2, and Id-3 co-expression correlates with prognosis in stage I and II lung adenocarcinoma patients treated with surgery and adjuvant chemotherapy.
    Antonângelo L; Tuma T; Fabro A; Acencio M; Terra R; Parra E; Vargas F; Takagaki T; Capelozzi V
    Exp Biol Med (Maywood); 2016 Jun; 241(11):1159-68. PubMed ID: 26869608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous apoptosis is inversely related to intratumoral microvessel density in gastric carcinoma.
    Lu C; Tanigawa N
    Cancer Res; 1997 Jan; 57(2):221-4. PubMed ID: 9000558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrences in stage II rectal carcinoma after curative resection alone: from the viewpoint of angiogenesis.
    Martinović Ž; Kovač D; Martinović C
    World J Surg Oncol; 2016 Apr; 14():122. PubMed ID: 27102733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
    Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.
    Gasparini G; Weidner N; Bevilacqua P; Maluta S; Dalla Palma P; Caffo O; Barbareschi M; Boracchi P; Marubini E; Pozza F
    J Clin Oncol; 1994 Mar; 12(3):454-66. PubMed ID: 7509851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of micropapillary pattern in lung adenocarcinoma and expression of apoptosis-related markers: caspase-3, bcl-2, and p53.
    Cakir E; Yilmaz A; Demirag F; Oguztuzun S; Sahin S; Yazici UE; Aydin M
    APMIS; 2011 Sep; 119(9):574-580. PubMed ID: 21851414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathology and genetic profile of synchronous multiple small adenocarcinomas: implication for surgical treatment of an uncommon lung malignancy.
    Lin MW; Wu CT; Kuo SW; Chang YL; Yang PC
    Ann Surg Oncol; 2014 Aug; 21(8):2555-62. PubMed ID: 24643899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinomas?
    Giatromanolaki A; Sivridis E; Koukourakis MI; Georgoulias V; Gatter KC; Harris AL
    Oncol Res; 1999; 11(4):205-12. PubMed ID: 10566619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes.
    Maeda R; Ishii G; Ito M; Hishida T; Yoshida J; Nishimura M; Haga H; Nagai K; Ochiai A
    J Thorac Oncol; 2012 Mar; 7(3):503-11. PubMed ID: 22198428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.